alpha blocker


Also found in: Dictionary, Medical, Wikipedia.
  • noun

Synonyms for alpha blocker

References in periodicals archive ?
Dizziness, low blood pressure, and fatigue can occur with alpha blockers.
Medical expulsive therapy (MET) administered with calcium channel blockers (nifedipine) or alpha blockers increase the chance of spontaneous passage in over 80% of cases for ureteral stones.
In the ALLHAT study, diuretic drugs were compared to angiotensin-converting enzyme (ACE) inhibitors that widen blood vessels and decrease resistance, calcium channel blockers that relax vessels by slowing the flow of calcium into the heart and alpha blockers, which also relax blood vessels.
The treatment regimen included an alpha blocker alone in five studies (including tamsulosin in four), tamsulosin with corticosteroids in one, nifedepine alone in one and nifedepine with corticosteroids in three.
Evaluated in this trial for CP/CPPS, RAPAFLO(R) is a uniquely selective alpha blocker approved for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), commonly referred to as an enlarged prostate.
Hypersensitivity to the particular alpha blocker agent.
There is evidence that discontinuation of an alpha blocker after a period of combination therapy may provide durable symptom relief.
6) Initial studies for the assessment of finasteride in combination with terazosin, doxazosin or alfuzosin were of short duration (6 months to 1 year) and failed to establish a benefit for combination therapy over placebo or alpha blocker monotherapy in terms of symptom improvement.
A review of 53 cases of ruptured pheochromocytoma revealed that 17 (32%) of the patients died, and that no mortality occurred among the 12 patients who received an alpha blocker (for high blood pressure) and fluid infusion therapy before surgery.
Alpha blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5-alpha reductase inhibitor dutasteride.
RAPAFLO[R] is an effective and uniquely selective alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), the number one reason patients visit urologists.
Watson recently launched RAPAFLO(TM) (silodosin), the company's new alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) and GELNIQUE(TM) (oxybutynin chloride) gel 10%, the first and only topical gel for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.